Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.070
0.00 (0.00%)
At close: Sep 17, 2025, 4:00 PM EDT
1.110
+0.040 (3.74%)
Pre-market: Sep 18, 2025, 5:26 AM EDT
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $139.79 million as of September 18, 2025. Its market cap has increased by 223.48% in one year.
Market Cap
139.79M
Enterprise Value
135.08M
1-Year Change
223.48%
Ranking
Category
Stock Price
$1.07
Market Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $139.79M, a decrease of -72.81%. That is a compound annual growth rate of -28.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 139.79M | 207.95% |
| Dec 31, 2024 | 45.39M | -23.95% |
| Dec 29, 2023 | 59.69M | 12.22% |
| Dec 30, 2022 | 53.19M | -73.09% |
| Dec 31, 2021 | 197.66M | -61.55% |
| Oct 14, 2021 | 514.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 688.88B |
| Johnson & Johnson | 424.11B |
| AbbVie | 382.50B |
| UnitedHealth Group | 309.39B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 231.45B |